Table Of Content

STATISTICS IN MEDICINE Statist. Med. 18, 3519-3522 ( AUTHOR INDEX Aalen, O.O0. 2087 Burgard, M. 815 Devane, J. 1865 Afifi, A. A. 893 Burke, M. 93 Diehr, P. 539 Agresti, A. 2189 Buyse, M. 3435 Diggle, P. 189, 1605 Aitkin, M. 2343 Diletti, E. 93 Albert, J. H. 287 ‘ampbell,M . J. 2077 Ding, Y. 907 Albert, J. M. 1615 andalh, E. 1849 Dirschedl, P. 2123 Albert, P. S. 1707 ‘ao, X. 3189 Douglas, J. A. 2917 Albrektsen, G. 1261 ‘apelozzi, V. 1401 Doyle, M. T. 1641 Alexander, F. E. 1501 ‘apocaccia, R. 44] Duffy, S. W. 2815 Alonzo, T. A. 2987 ardinal, M. 2025 Dukes, K. A. 855 Ananth, C. V. 2011 ‘ardon, L. R. 741 Dunn, G. 2863 Andersen, P. K. 1023 ‘arlin, B. P. 1307 Dunne, A. 1865 1529 ‘arlin, J. B. 2655 Andre, C. D. S. 1401 ‘arrat, F. 3463 Edler, L. 3435 Anello,C . 2301 astelluccio, P. 1171 Edmunds, W. J. 3263 Armstrong,M . P. 497 ‘atalano, P. J 213 Edwards, D. 771 Asefa, M. 835 ‘hang, A. M. Z. 1101 Elian, S. N. 1401 Ash, A. 375 ‘harles, M. W. 17 Elliott, P. 189, 2377 Asselain, B. 1791 hen, C. H. 1279 Elston, R. C. 741, 2961 Assuncao, R. M. 2147 ‘hen, D.-T. 799 Esbjerg, S. 1691 Atkinson, A. C. 1741 ‘hen, J. B. 1279 Estey, E. H. 1155 Aydemir, S. 2123 ‘hen, J. J. 799 Evans, B. 539 Aydemir, U. 2123 ‘hen, M.-H. 2435 Evans, S. 3435 ‘hen, R. 3299 Babiker, A. G. 1215, 261 ‘hen, T. T. 2691 Fagerstrom,R . M. 155 Bandeen-Roche, K. 2899 ‘hevret, S. 1803, 1821 Farewell, V. T. 69, 1- Banks, D. 727 ‘hinchilli, V. M. 3037 Farrington, C. P Barnhart, H. X. 199, 1419 hmiel, J. S. 1069 Fay, M. P. 273 Bashir, S. A. 2815 ‘ho, M. 1555 Feinstein, A. R. 255 , 2591 Bauer, P. 1833 ‘hoi, S. C. 1295 Feng, Z. 539 Beacon, H. 1657 ‘houquet, C. 815 Ferreira, A. F. 1401 Bebchuk, J. D. 213 ‘hristian, M. C. 2691 Finch, S. J. 1279 Begg,M . D. 1087 ‘larke, R. 1657 Finkelstein, D. M. 1341, 2737, Belin, T. R. 3123 ‘leary, P. D. 935 3089. 3101 Beresford, S. 539 ‘oad, D. S. 761 Fitzmaurice, G. M. 213 B3ereltienn,s kyJ,. AR.. 3A0.2 1 3089, 3101 offey, C. S. 1199, 2655 Flanders, W. D. 2795 ‘ollett, D. 2209 Fong, D. Y. T. 2365 Bigger, Jr, J. T. 1943 ‘olton, T. 3379, 3435 Fraser, G. E. 397 Bilker, W. B. 3021 ‘ook, R. J. 69, 175 Freedman, L. S. 2583 Blanche, S. 815 ‘ooper, M. D. 223 Frost, C. 1657 Borgdorff, M. 307 ostagliola, D. 815, 1031, 1803 Fryback,D . G. 1355 Boshuizen, H. C. 681 ‘raig, B. A. 1355 Fung, W. K. 1993 Brandwein, H. 1279 ‘rowley, J. 695, 2635 Brant, R. 2593 ui, J. $27 Gail, M. H. 3021, 3389 Breslow, N. 643 Gay, N. J Bridges, K. D. 423 D’ Agostino, Snr, R. B. 2551 Geller, N , 3435 Briggs, A. H. 3245 Darbyshire, J. H. 1215, 2617 Gelman, A Brittain, E. 3481, 3493 Davis,C . S. 567 George, S. I Brizendine, E. J. 557 Davis, W. W. 3189 Gillis, A. M. 139 Broekmans, J. 307 Day,N . E. 2815, 2831 Goetghebeur, E. J. T. 2449 Broét, P. 1791 De Angelis, R. 441 Goggins, W. B. 2737 Brown, B. W. 3075, 3137 Denne, J. S. 1575 Gomes, L. F. A. M. 3345 Brumback, B. A. 2163 Deuffic, S. 1031 Gong, G. 3321 AUTHOR INDEX jooley. T. A. 695 Keiding, N. 1691, 2353 ipsitz, S. f raf, E. 2529 Kelly, C. 2041 2449 ireenhalgh, D. 1641 Kenward, M. G. 2449 ittle, M. P ireenhouse, S. W. 3401 Kher, U. 2177 ittle, R. J ireenland, S Kieser, M. 93, 1833 iu, K. 655 jrove. D. 1387 Kirwan, J. R. 1677 meford, N. T. 1467, 231] muSKY. () Klein, B. E. K. 1355 ongini, Jr., I.M . 53 suIpp ti Klein, J. P. 1489, 1529 sina, E. 855 Klein, R. 1355 ouis, T. A. 2493 Haber, M Knook, D. L. 681 ovato, J 137 Hakulinen Koch, G. G. 989, 2585 ui, K.-J. 2041 Hall, C. B Koch-Henriksen, N. 1691 yles, R. H. 35, 1069 Hall, M.M Koepsell r. D. 539 Halloran, M Kooperberg, C. 3111 McDermott, M. P. 2051 Hanfelt, J. J Korhonen, P. A. 2879 McIntosh, M. W. 2775 Hannan, P. J. 655 Korn, E. L. 2691 Mah,, C. 1821 Hansen Simonson Kosinski, A. S. 199, 2795 Malec, D. 3189 Hauschke, D. 93 Kosorok, M R. 613 Malina, R. 1049 Hazlett, L. J. 42 Kowalski, J. 3059 Mander \ P 27( He, X. 1993 Kramar, A. 1849 Marchi, M. 2111 Heisterkamp, S. 307 Kunselman, A. R. 947 Marshall, R. J. 272 Heitjan, D. F. 2421 Kupper, L. L. 1475 Mascha, E. 1983 Helms, R. W. 1249 Kvale, G. 1261 Matkovich, V. 1279 Henslee-Downey, P. J 42 2 Matsui, S. 2409, 3005 Hess, K. R. 3075 achenbruch, P. 3435 Mayaux, M.-J. 815 Heuch, I. 1261 agakos, S. W. 2287 Mayo, M. S. 223 Heyd, J. M. 1307 aird, N. M. 2879 Medley, G. F. 3263 Hilsden, R. 2593 ambert, J. 2025 Meinert,C . L. 241 Hin, L. Y. 1101 amm, C. J. 2709 Melbye, M. 1023 Hirji, K. F. 893 ampugnani, L. 2111 Mezzetti, M. 919 Holcomb, Jr., J. P. 2847 anden, D. D. 3355 Michiels, B. 2449 Holmes, L. B. 2163 andrum, M. B. 117 Midthune, D. 2691 Horowitz, M. M. 1529 ange, N. 2401 Miller, W. E. 975 Horton, N. J. 213 arsson, P. 629 Mira, A. 2507 Hoseyni, M. 1541 au, T. K Miyagishi, H. 3005 Hu, F. 1757 awless, J Molenberghs, G. 2237, 2449 Hu, M.-Y. 3123 e Corfec Mooney, C. Z. 3245 Hu, X. J. 2287 e Strat, Y Moreau, T. 1791 Hudgens, M. G. 53 ebecq, A Morris, S. 1605 Hughes, M. D. 2709 eBlanc, M. 2635 Morton-Jones, T. 189, 1605 Hui, S. L. 1171 se, J.C. 799 Muirhead, C. R. 17, 1501 Hung, H.-N. 799 se, J.J. 1155 Mukherjee J. 175 Hutton, J. 3435 se, P. N. 1973 Miiller, H.-H. 1769 Hwang, J.-S. 1627 se, S.-Y. 2933 Miiller, K. E. 1199 “ce, W.-C. 455. 2645 Mungiole, M. 3201, 3211 Ibrahim, J. G. 473, 2435 ee, Y. J. 1295 Mufioz, A. 1069 idury, R. M. 741 eisenring, W. 695 Mufioz, P. 2077 Ishiguro, M. 581, 601 ellouch, J. 1791 Murray, G. 3435 eong, T. 473 Jacobs, Jr, D. R. 655 roux, B. G. 643 Nagelkerke,N . J. D. 307 Jadad, A. R. 3409 esaffre, E. 835, 2237, 2449. Narula, S.C. 1401 Jennison, C. 1575 3435 Nelder, J. A. 2311 Jia, G. 3059 evin, B. 1943 Ng, E. T Jiang, G. 1133 ewis, C. E. 655 Nobre, F. I Jolliffe, 1. T. 1879 ewis, J. A. 1903 Nokes, D. J Jones, C. L. 213 i. J. 3337 Normand, S$ Jones, G. K. 3211 jaw, Y.-P. 2645 Jorgensen, B. 2257 ichter, J. B. 741 Ockene, I. 2943 Jung, J.-W. 989 in, C.-Y. 385 O'Hara, T. 1865 in, X. 2479 Ohashi, Y. 1961, 2409 Kafadar, K. 3167 in, Z. 365 Oldehinkel, A. J. 1111 Kalén, A. 629 indsey, J. K. 2223 Olkin, I. 2331 AUTHOR INDEX Olson, J. M. 2961 Russell, K. 3137 Tran, L. 947 Omar, R. Z. 1587 Russell, L. B. 3235 lritchler, D. 2067, Oppenheimer, L. 2177 Ryan, L. M. 2163, 2479 Troendle, J. F. 27€ O’ Quigley, J. 2683 Trotta, L. T. I Osnes. K. 707. 2087 Saez, M. 2077 Tsai, W. Y. 194 Sagatelian, K. 53 Tsao, M. 2257 Paik, M. C. 1943 Saldiva, P. H. N. 1401 Tseng, C.-H. 1155 Palmgren, J. 2879 Sammel, M. 2479 Tu, W. 2749 Palta, M. 385 Sampson, A. R. 199 Tu, X. M. 3059 Pan, W. 3111 Sarkar, S. K. 1133 Turner, R. M. 1587 Pan, Z. 1475 Sauerbrei, W. 2529 Panageas, K. S Schabenberger, O. 3481, 3493 van Buuren, S. 681 Paramithiotis, f Schafer, H van Houwelingen, H. 307 Park, T. 2933 Scherrer, B Vanbrackle, L. 3309 Parrish, R. S. 423 Schmidtmann, I. 1501 Vaughan, D. 175 Patton, G. C. 2655 Schmoor, C. 2529 \ erbeke, G Penny, K. I. 1879 Schoenfeld, D. A. 13 Verdecchia, A Pepe, M. S. 163, 2987 Schouten, H. J. A. 87 Verma, B. | Perisic, I. 1451 Schubert, A. 1983 Peterson, H. 2435 Schumacher, M. 2529 Wakefield, J. 23 Pickle, L. W. 3201 Scott, A. J. 1373 Walker, S. 2617 Platt, R. W. 643 Seidel, K. 163 Wallace, D. 655 Pocock, S. J. 1215 Serachitopol, D. M. 3075 Walter, S. D. 3409 Preisser, J. S. 2011 Shannon, W. D. 727 Wang, J.-D. 1627 Prentice, R. L. 2517 Sharp, S. J. 2693, 2709 Wareham, N. | Prescott, P. 265 Shavlik, D. J. 397 Wassell, J. T Price, P. N 23 99r1ae | Sheldon, R. S. 139 Wassmer,G . 3453 Pritz, M. B 557 Shen, L. Z. 1541 Weatherby Hudson, G. 3283 Prorok, P. C. 155 Shen, W. 2493 Weeden, S. 1677 Proschan, M. A. 787, 3481 Shih, W. J. 961 Weinberg, C. R. 411 Province, M. A. 1517 Shwartz, M. 375 Weiss, R. E. 1555 Pukkala, E. 1501 Siegmund, K. D. 15] Well, A. 2943 Pulkstenis, E. 1541 Simon, R. M. 2691 Wenz, B. 1279 Putt, M. 3037 Snapinn, S. M. 1249 Whitaker, R. C. 163 Socie, G. 1529 Whitbread, J. 1279 Qu, R. 613 Soderman, B. 441 White, A. A. 3211 Qu, Y. 1983 Sposto, R. 1183 White, I. R. 2617 Quan, H. 961 Sprott, D. A. 1435 Whitehead, J. 2271, 3425 Stanek III, E. J. 2943 Whittemore, A. S. 3321 Raghunathan, T. 2465 Steiner, S. H. 69 Williams, O. D. 65 Ranstam, J. 343 Stepniewska, K. 2209 Williams, T. V. 93 5S Rao, J. N. K. 1373 Stewart, W. F. 2899 Williamson,G . D. 3283, 3309 Stiger, T. R. 1419 Reis, I A 2147 Williamson, J. M. 1419 Reis, I. M. 893 Stiller, C. 1501 Witte, J. S. 2961 Reitmeir, P. 3453 Stone, J. V. 1529 Wittes, J. 3379, 3381, 3481, Richardson, S. 815 Storer, B. E. 695 3493 Roberts, C. 2605 Stram, D. O. 1183 Wohlfahrt, J. 1023 Robertson. C. 919 Strom, B. L. 3021 Wojciechowski, W. C. 3355 Rodenberg, C. A. 1171 Sullivan, L. M. 855 Wolfe, R. 2655 Rogers, M. S. 1101 Sutherland, L. 2593 Wonderling, D. E. 3245 R6hmel, J. 2321 Wong, M. Y. 2815, 2831 Rose, M. S. 139 Tan, M. 1983 Wray, N. R. 1501 Rosen, O. 1119 Tanner, M. 1119 Wright, E. M. 1587 Rosenberger, W. F. 761, 1757 Taylor, J. M. G. 1069 Rosner, B. 1387, 1451 Ten Have, T. R. 947 Xu, J. 35, 1069 Rossi. G 21 l | hall, P. F. 1155 Xu, J.-L. 155 Rottman, J. N. 1943 Thompson, S. G. 1587, 2693 Xue, X. 907 Rouzioux, C. 815 Tierney, L. 2507 Roy, R. 2025 Tobias, A. 2077 Yafune, A. 581, 601 Rubenstein, L. M. 567 Todorov, A. A. 1517 Yamaguchi, T. 196! Rubinstein, L. V. 2691 Tomasko, L. 1249 Yanuzzi, M. 1555 Rushton, G. 497 Touloumi, G. 1215 Yasui, Y. 539 AUTHOR INDEX Young, A. S. 312 Zaslavsky, A. M. 935, 2737 hou, X.-H. 557, 1171, 2749 Young, P. J. 1677 Zeger, S. L. 2899 Zimmerman, D. L. 497 hang, M.-J. 1489, 1529 Zou, K. H. 2051 Zahner, G. E. P. 213 Zhou,H . 411 Zucker, D. M. 3481, 3493 STATISTICS IN MEDICINE Statist. Med. 18. 3523-3548 (1999) SUBJECT INDEX* Votes: Single page numbers refer to individual papers ) after some numbers indicate letters Aalen model, failure time data 2123 Age-specific back-calculation, cancer incidence rates Absolute risk, tumours | 919 Accelerated failure time model, ATBC study \ge-time specific infection incidence 307 non-compliance 2879 ncy for Toxic Substances and Disease Registry Accrual rates, ICH guidelines 1905 (ATSDR), ‘Statistical bases for public health Accrual strategies, phase I trials 1155 decision making: from exploration to modeling’ Acute myeloblastic leukaemia, macrophage colony 3159-3375 stimulating factor (M-CSF) 2409 \ggregate analysis, variation in outcome between Acute myelogenous leukaemia (AML) professionals 2605 covariate adjusted mortality 1529 Aggregation, geographic masking 497 multi-centre survival studies 1489 AIDS Acute myocardial infarction (AMI) Bayesian approach 3059 coronary angiography guidelines 117 biomarkers variability 1069 meta-analysis 2343 group sequential analyses 2287 Adaptive designs incidence estimation 527 bootstrap 1757 incubation time 1031 randomized play-the-winner rule 761 Kendall’s coefficient of concordance extension \daptive two-stage design, single confirmatory trials 3101 1833 mortality and longitudinal measures combination Additive effect, model prespecification 771 1341 Adjusted expected length of stay (AELOS), lifetime non-parametric maximum likelihood estimator models 3337 3089 Adolescent Health Cohort Study 2655 random effects predictors 35 Adverse effects, chorionic villus sampling 2163 threshold causal model 1615 Affine transformations, confidentiality 497 treatment changes correction 2617 Age visit-driven endpoints 1803 cancer risk 126] Akaike’s information criterion (AIC) 2209 repeated measures regression analysis 655 generalized linear models 2223 simultaneous smoothing and adjusting mortality hierarchical linear modelling 855 rates 3167 Alpha trial, informative drop-outs 1215 tumour risk 17 Alpha-tocopherol beta-carotene (ATBC) study, Age-adjustment of rates, optimal weighting systems non-compliance 2879 2645 Anaemia, covariate adjusted mortality 1529 \ge-at-exposure (AAE), radiation induced tumours \naesthesiology, Bayesian hierarchical model 1983 17 Analysis of covariance (ANCOVA) \ge-at-onset group sizes 255 frailty approach 1517 measurement error 2863 MS reporting delay and corrected incidence 1691 missing data 2465 multivariate exponential hazard rate model 397 repeated measurements data 1587 Age-period-cohort models, chronic disease rates Analysis of variance (ANOVA) 1733(L) dose response studies 629 *Author and subject indexes were compiled by Indexing Specialists, 202 Church Road, Hove, East Sussex BN3 2DJ, UK SUBJEC I INDEX Bayes factors, hierarchical models 287 nternal ed Bsayaevse s pprree dictor, random effects 35 magnetic sonance neuroimaging 2401 Bayesian a IrNi ! acl h | 9] meta-analvys 33) age-specific back-calculation ancer inciden Anscombe eighting procedure (ANS) 1993 rates 919 Anxiety liscriminant analysis 1249 autoregressive models 2709 AUC chronic conditions natural hist drug dissolution data 799 itration-time curve 1133 heterogeneity in meta-analysis geographic masking 497 HIV | transmission 815 integrated, moving innovations 2493 medical guidelines meta-analysis 321 Scales 2 AIMS2) mixture likelihoods and priors overweight prevalence 3189 parameter estimate maps 3221 \ ei ly prevalence 3059 Association models ordered categorical data 219] small area health data 2377 As thma spatial smoothing 2087 iuloregre models 2709 Bayesian hierarchical model, multi-level repeated se-control isotonic regression 1605 ordinal data 1983 GEI ving average analysis 20 Bayesian inference measurements data 1587 adaptive Monte Carlo methods 2, 507 Asymptotic power calculations 3137 bivariate frailty model 907 Asymptotic relative efficiency (ARE) ordered categorical data 2191 disease outcome status verification 3021 Bayesian information criterion (BIC) 855, 2209 wrank test 179] Bernoulli probability, case-distribution studies | ymptotic tests Best linear unbiased estimates (BLUEs), cholesterol bioavailability trials 1133 estimates 2943 homogeneity 893 Best linear unbiased predictors (BLUPs) \TBC study see Alpha-tocopherol beta-carotene cholesterol estimates 2943 study hierarchical linear modelling 855 \ is of U7 ited States Mortality 211 Beta-blockers, meta-analysis 2343 Autocorrelation, spatial 2087 Between-community variance, group randomized Automatic stepwise selection, binary data 2209 trials 539 \utoregressive, integrated moving average Between-strata balanced designs 893 ARIMA) 2025 Between-strata unbalanced designs 893 National Notifiable Diseases Surveillance Systet Bias 3409 bivariate multi-state Markov transition model 16 health surveillance reports 3283 confirmatory randomized studies 771 tressive models, non-linear changes 2709 cost-effectiveness ratios confidence intervals 3245 ge at onset, multivariate exponential hazard direct and indirect effects 2101 rate model 397 exposure misclassification 2795 rage run length, national notifiable diseases fecundability parameters 41 | surveillance system 3309 group sequential designs 2635 age treatment effect, bias and ignorability 224A2M1 ignorability 2421 measurement error 2815, 2831 population pharmacokinetics 601 B lymphocyte migration 22 responder analysis 2177 Back-calculation time to the first event 139 AIDS incubation time 1031 two-phase design study 1171 ancer incidence rates 919 Binary data 2209 mother-to-child HIV-| transmission 815 correlated 69 Baseline risk meta-analysis 233(L) latent variable model 385 SUBJECT INDEX longitudinal studies 2655 multi-armed controlled clinical trials 787 Binary responses multiple comparison 1475 clinical trials 761 multiple endpoints 3453 mixed effects logistic regression 947 Book reviews Binomial distribution, leukocyte-reduced red cell Afifi, A. A. & Clark, V , Computer Aided blood products 1279 Multivariate Analysis (3rd edn) 624 Binomial model, heterogeneity in meta-analysis 2693 Andersen, E. B., Introduction to the Statistical Binomial outcomes, comparisons of two groups 2551 Analysis of Categorical Data 2547 Binomial proportions on paired data, confidence Anderson, T. W. and Finn, J. D., The New intervals 351 1(1 Statistical Analysis of Data 1019 Bioavailability trials, repeated measures 1133 \.V. Panfilov and A.V. Holden (eds), Biomarkers Computational Biology of the Heart 239 validation studies 2815, 2831 Babbie, E. and Halley, F., Adventures in Social variability, measurement error 1069 Research. Data Analysis usine SPSS for Birth defects data, multivariate linear mixed models Windows 2550 2479 Bowers, D., Statistics further from Scratch: For Birth weight Health Care Professionals 1291 bivariate logistic regression 201 | Butler, B. P., Cox, M. G., Ellison, S. L. R. & mixture likelihoods and priors 1555 Hardcastle, W. A. (eds), Statistics Software Birthday problem 223, 1641 Qualification: Reference Data Sets 495 Bivariate censored data, linear regression 3111 Byrne, D. W., Publishing Your Medical Research Bivariate data, average correlation coefficient Paper: What They Don’t Teach in Medical estimation 567 School 2809 Bivariate frailty model, paired failure times 907 Carlin, B. C. & Louis, T. A., Bayes and Empirical Bivariate interval censored data Bayes Methods for Data Analysis 625 Kendall’s coefficient of concordance 3101 Coakes, S. J. and Steed, L. G., SPSS Analysis non-parametric maximum likelihood estimator Without Anguish 2984 3089 Dowdle, W. R. and Hopkins, D. R., The Bivariate log-spline density estimation approach Eradication of Infectious Diseases 755 3111 Everitt, B. S. & Rabe-Hesketh, S., The Analysis of Bivariate logistic regression, twin gestations 2011 Proximity Data 491 Bivariate multi-state Markov transition model 1677 French, S. and Smith, J. Q., The Practice of Bivariate multiplicative frailty, two-state mixed Bayesian Analysis 2813 renewal processes 175 Gerber, S. B. and Voelkl, K. E., The SPSS Guide Bivariate outcome, cumulative sum charts 69 to the New Statistical Analysis of Data 1021 Bivariate survivor function, non-parametric Glantz, S. A., Primer of Biostatistics 2548 maximum likelihood estimation 2517 Grayson,L., Scientific Deception: An Update 760 Bladder cancer, multi-centre trials 1961 Hald, A., A History of Mathematical Statistics Blood cholesterol, meta analysis hierarchical models from 1750 to 1930 1572 1657 Hettmansperger, T. P. and McKean, J., Robust Blood counts, rejection procedures 3401 Nonparametric Statistical Methods 1899 Blood pressure Hinde, A., Demographic Methods 3154 multi-armed controlled clinical trials 787 Holland, B. K., Probability Without Equations random effects predictors 35 Concepts for Clinicians 622 survival analysis 681 Howe, G. M., People, Environment and Death 621 BLUEs see Best linear unbiased estimates Iversen, G. R. and Gergen, M., Statistics, The BLUPs see Best linear unbiased predictors Conceptual Approach 2549 Body mass index (BMI), obesity prediction 163 Kolman, J., Meng, P. and Scott, G. (eds), Good Bone marrow transplantation Clinical Practice. Standard Operating GVHD multivariate approach 423 Procedures for Clinical Researchers 2985 observational epidemiology 2353 Koul, H. L. and Deshpande, J. V. (eds), Analysis of Bonferroni method Censored Data 1900 bioavailability trials 1133 Lang, T. A. and Secic, M., How to Report candidate genes 741 Statistics in Medicine: Annotated Guidelines SUBJECT INDEX for Authors, Editors and Reviewers 2809 National Notifiable Diseases Surveillance System Lauritzen, S. L., Graphical Models 2983 3309 I e, hy Applied Survival Analysis 492 public health surveillance reports 3283 Lee, P. M., Bayesian Statistics An Introduction Boxing, neuropsychological effects 2899 (2nd ed) 2812 Breast cancer Lindsey, J. K., Introductory Statistics 4 Modelling collinearity 1261 Approach 75° Maximin efficiency robust test 1791 McFadden, E., Management of Data in Clinical multivariate competing risks 1023 Trials 626 non-ignorable missing covariates 2435 Machin, D., Campbell, M. J., Fayers, P. M. & population-based case-control data 3321 Pinol, P. Y., Sample Size Tables for Clinical post-lead-time survival 155 Studies 494 prognostic classification schemes 2529 Maruyama, G. M., Basics of Structural Equation screening trials 2775 Modeling 157\ spatial smoothing 2087 Maynard, A. and Chalmers, I., Non-random study quality modelling 2135 Reflections on Health Services Research: On Breslow estimator, interval censored latency data 2737 the 25th Anniversary of Archie Cochrane's Effectiveness and Efficiency 891 Breslow T test, geographic disease incidence 1501 Mueller, R. O Basic PrincipIl es of Structural Breslow-Day test, homogeneity 893 Equation Modeling. An Introduction to Brier score, prognostic classification schemes 2529 LISREL and EQS 757 Bronchitis, two-state mixed renewal processes 175 Ogden, R l., Essential Wavelets for Statistical Brownian motion approximation, sequential clinical Applications and Data Analysis 627 trials 2271 Pace, I & Salvan, A., Principles of Statistical ‘Burning issues’ conference, De Montford University Inference fro a Non-Fisherian Perspective 2189 623 Riedwyl, H., Linear Regression und Verwandtes 1022 C statistic, dichotomous outcomes 375 Selwyn, M. R., Principles of Experimental Design Caesarian delivery, generalized additive modelling for the Life Sciences 2986 1101 Sprent, P., Data Driven Statistical Methods 3153 Calculated variables, SIMEX method 2847 Vedel Jensen, I B., Local Stereology 3155 Cancer Yakovlev, A. Y and Tsodikov, A. D., Stochastic age-specific back-calculation of incidence 919 Models of Tumor Latency and their ATBC study non-compliance 2879 Biostatistical Applications 3156 case-control isotonic regression 1605 Bootstrap method cluster localization 707 adaptive designs 1757 collinearity 1261 binary data 2209 continual reassessment methods 1849 confidence intervals 557, 581, 601 failure probabilities 695 cut-off tests 3453 familial aggregation 3389 group sequential designs 2635 group sequential designs 2635 incremental cost-effectiveness ratio (ICER) 3245 Maximin efficiency robust test 1791 longitudinal studies binary outcomes 2655 mortality spatial patterns 3211 quality-adjusted survival 1627 multi-centre trials 1961 threshold causal model 1615 multivariate competing risks 1023 two-phase design study 1171 non-ignorable missing covariates 2435 variation in outcome between professionals 2605 phase I trials accrual strategies 1155 Wilcoxon’s rank-sum test power 2763 population-based case-control data 3321 Zhou and Gao paper correction 889 post-lead-time survival 155 Boundary effects, hazard function estimators 3075 prognostic classification schemes 2529 Box-Cox power transformation, drug dissolution data radiation induced tumours 17 799 randomized trial design 1183 Box-Jenkins models screening trials 2775 = disease incidence 2025 spatial smoothing 2087 SUBJECT INDEX study quality modelling 2135 ‘horionic villus sampling, adverse effects 2163 survival analysis, mixture models 44] ‘hronic conditions natural history, Bayesian weighted head-banging algorithm 3201 approach 1355 ‘andidate genes, drug trials 741 hronic disease rates, age-period-cohort models Carcinogens 3389, 3401 1733(L) ‘ardiovascular disease, predictive agreement 1435 ‘hronic graft-versus-host disease (CGVHD) 695 arstairs index, environmental risk 189 ‘lassical occupancy problem 1641 ‘ART see Classification and regression tree analysis ‘lassification errors, group testing 1049 ‘ase-control isotonic regression, point sources 1605 ‘lassification and regression tree (CART) analysis ‘ase-control studies 727, 2529, 2723 early stopping 361(L) ‘lassification trees error checking 1973 maximum likelihood estimate 727 logistic regression 3389 ordinal categories classification 2723 meta-analysis 2163 ‘linical trials population-based 3321 see also Phase | trials; Phase II trials; Randomized ‘aSe-CrOss-Over study | trials ‘ase-distribution studies, unified approach | bias and ignorability 2421 ‘ategorical data, ordered, modelling 2191 design and monitoring, meta-analysis 753(L) ategorized variables 1905 fraud 3435 ‘D4 counts intended treatment departures 1615 biomarkers variability 1069 interim analyses with delayed observations 1297 informative drop-outs 1215 longitudinal data 1707 mortality and longitudinal measures combination mortality and longitudinal measures combination 134] 134] multiple comparison studies ‘ 1475 multi-armed controlled trials 787 randomized HIV/AIDS clinical trials 1803 multiple endpoints 3453 threshold causal model 1615 observational studies 2365 ensoring quality of life 2917 ATBC study non-compliance 2879 randomized HIV/AIDS trials 1803 bivariate censored data linear regression 3111 randomized play-the-winner rule 76] Cox proportional hazards model 273 repeated measures 961 generalized linear models 1OBK selection bias 1467 lifetime data medians 1993 sequential 2271 prognostic classification schemes 2529 statistical principles 1905 treatment changes correction 2617 treatment heterogeneity 1467 enter for Drug Evaluation and Research (CDER) triangular test 761 2301 vaccine efficacy 53 ‘enters for Disease Control and Prevention (CDC), ‘luster localization, spatial autocorrelation 707 ‘Statistical bases for public health decision ‘luster sampling, odds ratio interval estimation 1087 making: from exploration to modeling’ ‘lustered data, Mann-Whitney U-test 1387 3159-3375 ‘lustered Poisson data, overdispersion 1373 entre effects lustering multi-centre survival studies 1489 bivariate logistic regression 201 | multi-centre trials 1961 cumulative g interval curve 3299 ‘hi-square test, homogeneity 893 geographic disease incidence 1501 ‘hildhood leukaemia, geographic disease incidence mixed effects logistic regression 947 1501 Nathan Mantel’s work 3389 ‘hildhood Predictors of Adult Obesity (CPAO) 163 small area health data 2377 hlamydia trachomatis detection, reference tests oarse data model 2421 2987 oarsened completely at random (CCAR) 2421 Cholesterol ‘ochran-Mantel-Haenszel (CMH) correlation best linear unbiased estimates (BLUEs) 2943 coefficient 567 best linear unbiased predictors (BLUPs) 2943 ‘ohort effects, repeated measures regression analysis meta-analysis 1657, 2693 655 SUBJECT INDEX Cohort model, vaccination programmes SAS GENMOD 1707 cost-effectiveness 3263 SAS PROC MIXED 321, 655, Cohort studies SPSS 2723 chronic conditions natural history 1355 ‘omputer-assisted new drug applications (CANDAs) disease outcome status verification 3021 2301 error checking 1973 oncordance, Kendall's coefficient, extension 3101 linear mixed model 835 ‘oncorde trial, treatment changes correction 2617 meta-analysis 2163 ‘onditional autoregressive (CAR) model, small area recurrent injury event-time analysis 3355 health data 2377 ollinearity, cancer risk 1261 ‘onditional coverage probability, early stopping olon cancer, mixture models 441 436 | { | } olumn effects model 2191 ‘onditional hazard functions, bivariate frailty model ommon odds ratio, interval estimation 1087 907 ommunity-by-time variance, group randomized ‘onditional inference, predictive agreement 1435 trials 539 ‘onditional likelihood, predictive agreement 1435 ommunity-level variance, group randomized trials ‘onditional logistic likelihood, case-distribution 539 studies | omparative analysis ‘onditional power, early stopping 361(L) biomarkers variability 1069 ‘onditional score tests, homogeneity 893 exact tests 1/34(L) ‘onditionally independent hierarchical models omparisons of two groups 255 (CIHM) 287, 557 2591 ‘onfidence intervals ompeting risks, failure probabilities 695 binomial proportions on paired data (L)3511 omplementary loglog, Bayesian analysis of bootstrap 581, 601, 1757 prevalence 3059 correlated binary proportions 109(L) ‘omplete-case analysis (CC), missing data 2465 cost-effectiveness ratios 3245 ompliance error checking 1973 cancer screening trials 2775 intraclass correlation coefficient 2051 measurement error 2863 recurrent events 2409 omposite reference standard (CRS) 2987 width, multiple comparison studies 1475 omposite variables 1905 ‘onfidentiality, geographic masking 497 ompound symmetry, group sizes 255 ‘onfirmatory randomized studies, model omputer Assisted Review of Safety (CARS) 2301 prespecification 771 omputer packages “onfirmatory trials 1905 BUGS 117, 321, 919, 1983, 2087, 2693, 2709 ‘onstant-effect models, recurrent events 2409 continual reassessment method 1155 ‘onstrained Bayes, random effects 35 EQS 2863 ‘ontinual reassessment method (CRM) 2691 FORTRAN 893, 3075, 313 adaptive design improvements 1307 GAUSS 385 delayed patient outcome 1155 GENMOD 3059 phase I trials 1849, 2683 GIS 497 ontinuous delay distribution, AIDS incidence 527 HLM/2L 855 ‘ontinuous measurements, dichotomization 1101 ICH guidelines 1905 ‘ontinuous outcome LISCOMP 385 planning group sizes 55 meta-analysis 32] responder analysis 2177 MIXOR 385 ‘ontinuous response variables, multi-level random MLn 2605 effects model 1215 MSAE 1401 ‘ontinuous time Markov process, HIV-1 ordered categorical data 2191 transmission 815 PRO MIXED 3037 ‘ontinuous variables, comparisons of two groups REML 539 2551 S-plus 1707, 3059, 3075 ‘ontrol charts SAS 1475 National Notifiable Diseases Surveillance System SAS GEE 385 3309